Nanoparticle Diagnostics and Theranostics in the Clinic

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2022 Oct 27

PMID 36302654

Authors

Roger M Pallares

Felix M Mottaghy

Volkmar Schulz

Fabian Kiessling

Twan Lammers

Affiliations

Soon will be listed here.

Abstract

Nanoparticles possess unique features that may be useful for disease diagnosis and therapy. Preclinically, many different nanodiagnostics have been explored, but only a few have made it to the market. We here provide an overview of nanoparticle-based imaging agents currently used and evaluated in the clinic and discuss preclinical progress and translational avenues for the use of nanoparticles for diagnostic and theranostic applications.

Citing Articles

Biomedical Metal-Organic Framework Materials: Perspectives and Challenges.

Wang A, Walden M, Ettlinger R, Kiessling F, Gassensmith J, Lammers T Adv Funct Mater. 2024; 34(43).

PMID: 39726715 PMC: 7617264. DOI: 10.1002/adfm.202308589.

Advances and prospects of precision nanomedicine in personalized tumor theranostics.

Mao Y, Xie J, Yang F, Luo Y, Du J, Xiang H Front Cell Dev Biol. 2024; 12:1514399.

PMID: 39712574 PMC: 11659764. DOI: 10.3389/fcell.2024.1514399.

Advancements in nanotechnology for diagnostics: a literature review, part II: advanced techniques in nuclear and optical imaging.

Butt A, Bach H Nanomedicine (Lond). 2024; 20(2):183-206.

PMID: 39670826 PMC: 11730800. DOI: 10.1080/17435889.2024.2439778.

Effect of laser photobiomodulation combined with hydroxyapatite nanoparticles on the osteogenic differentiation of mesenchymal stem cells using artificial intelligence: An in vitro study.

de Melo E, Miranda J, Lima V, Gaiao W, Tostes B, Rodrigues C PLoS One. 2024; 19(11):e0313787.

PMID: 39541307 PMC: 11563392. DOI: 10.1371/journal.pone.0313787.

Applications of Novel Microscale and Nanoscale Materials for Theranostics: From Design to Clinical Translation.

Tian M, Dong B, Li W, Wang L, Yu H Pharmaceutics. 2024; 16(10).

PMID: 39458667 PMC: 11511338. DOI: 10.3390/pharmaceutics16101339.

References

Kim J, Lee N, Hyeon T . Recent development of nanoparticles for molecular imaging. Philos Trans A Math Phys Eng Sci. 2017; 375(2107). PMC: 5647266. DOI: 10.1098/rsta.2017.0022. View

Miedema I, Zwezerijnen G, Huisman M, Doeleman E, Mathijssen R, Lammers T . PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients. Adv Mater. 2022; 34(21):e2201043. DOI: 10.1002/adma.202201043. View

Janjua T, Cao Y, Yu C, Popat A . Clinical translation of silica nanoparticles. Nat Rev Mater. 2021; 6(12):1072-1074. PMC: 8496429. DOI: 10.1038/s41578-021-00385-x. View

Iv M, Samghabadi P, Holdsworth S, Gentles A, Rezaii P, Harsh G . Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study. Radiology. 2018; 290(1):198-206. PMC: 6312434. DOI: 10.1148/radiol.2018181204. View

Taruno K, Kurita T, Kuwahata A, Yanagihara K, Enokido K, Katayose Y . Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe. J Surg Oncol. 2019; 120(8):1391-1396. DOI: 10.1002/jso.25747. View

Golombek S, May J, Theek B, Appold L, Drude N, Kiessling F . Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev. 2018; 130:17-38. PMC: 6130746. DOI: 10.1016/j.addr.2018.07.007. View

Thakor A, Jokerst J, Ghanouni P, Campbell J, Mittra E, Gambhir S . Clinically Approved Nanoparticle Imaging Agents. J Nucl Med. 2016; 57(12):1833-1837. PMC: 5126695. DOI: 10.2967/jnumed.116.181362. View

Biancacci I, Sun Q, Mockel D, Gremse F, Rosenhain S, Kiessling F . Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles. J Control Release. 2020; 328:805-816. PMC: 7611891. DOI: 10.1016/j.jconrel.2020.09.046. View

Sofias A, Toner Y, Meerwaldt A, van Leent M, Soultanidis G, Elschot M . Tumor Targeting by αβ-Integrin-Specific Lipid Nanoparticles Occurs Phagocyte Hitchhiking. ACS Nano. 2020; 14(7):7832-7846. PMC: 7392528. DOI: 10.1021/acsnano.9b08693. View

10.

Lu Y, Xu Y, Zhang G, Ling D, Wang M, Zhou Y . Iron oxide nanoclusters for T magnetic resonance imaging of non-human primates. Nat Biomed Eng. 2019; 1(8):637-643. DOI: 10.1038/s41551-017-0116-7. View

11.

Kiru L, Zlitni A, Tousley A, Dalton G, Wu W, Lafortune F . In vivo imaging of nanoparticle-labeled CAR T cells. Proc Natl Acad Sci U S A. 2022; 119(6). PMC: 8832996. DOI: 10.1073/pnas.2102363119. View

12.

Zhang R, Kiessling F, Lammers T, Pallares R . Clinical translation of gold nanoparticles. Drug Deliv Transl Res. 2022; 13(2):378-385. PMC: 9432795. DOI: 10.1007/s13346-022-01232-4. View

13.

Kallianos K, Henry T, Yeghiazarians Y, Zimmet J, Shunk K, Tseng E . Ferumoxytol MRA for transcatheter aortic valve replacement planning with renal insufficiency. Int J Cardiol. 2017; 231:255-257. PMC: 5303665. DOI: 10.1016/j.ijcard.2016.12.147. View

14.

Pathria P, Louis T, Varner J . Targeting Tumor-Associated Macrophages in Cancer. Trends Immunol. 2019; 40(4):310-327. DOI: 10.1016/j.it.2019.02.003. View

15.

Kim H, Li R, Ng T, Courties G, Rodell C, Prytyskach M . Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using Cu-Labeled Macrin. ACS Nano. 2018; 12(12):12015-12029. PMC: 6482841. DOI: 10.1021/acsnano.8b04338. View

16.

Schilham M, Zamecnik P, Prive B, Israel B, Rijpkema M, Scheenen T . Head-to-Head Comparison of Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients. J Nucl Med. 2021; 62(9):1258-1263. PMC: 8882902. DOI: 10.2967/jnumed.120.258541. View

17.

ReeBing F, Szymanski W . Following nanomedicine activation with magnetic resonance imaging: why, how, and what's next?. Curr Opin Biotechnol. 2018; 58:9-18. DOI: 10.1016/j.copbio.2018.10.008. View

18.

Centelles M, Wright M, So P, Amrahli M, Xu X, Stebbing J . Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours. J Control Release. 2018; 280:87-98. DOI: 10.1016/j.jconrel.2018.04.047. View

19.

Voskuil F, Steinkamp P, Zhao T, van der Vegt B, Koller M, Doff J . Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery. Nat Commun. 2020; 11(1):3257. PMC: 7320194. DOI: 10.1038/s41467-020-16814-4. View

20.

Verry C, Dufort S, Lemasson B, Grand S, Pietras J, Tropres I . Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective. Sci Adv. 2020; 6(29):eaay5279. PMC: 7439298. DOI: 10.1126/sciadv.aay5279. View